INSIGHTS ON QUALITY CONTROL

• CPhI North America 2026: CDMO Partnerships With Mikart

  Event-driven blogs highlighting how sponsors can evaluate CDMO partnerships, outsourcing strategies, and formulation development discussions across major 2026 industry conferences.

• Mechanical Engineering Design Process For Combination Products

  Mechanical engineering for combination drug-delivery devices demands more than good design — it requires data-driven risk management from specs through simulation. Learn how a structured phase approach ensures global manufacturing readiness.

• The Importance Of Container Closure Integrity

  From package design to advanced testing technologies, discover the critical elements of maintaining sterility and preserving product quality over time.

• Practical Considerations For Aseptic Gowning In Contamination Control Strategies

  Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  2/6/2026

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

• Improving Bioprocess Monitoring And Control With Multivariate Data Analysis

  12/9/2024

  Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.

• What Is LearnGxP?

  4/24/2026

  Stop the cycle of "click-through coma" in GXP training. Discover how scenario-based learning and role-specific curricula reduce compliance risks and drive meaningful engagement.

• 5 Must-Haves From Your Peptide Building Block Supplier

  7/24/2026

  Whether you are just entering the peptide market or scaling an established product, access to a reliable supply of high-quality building blocks is critical to running a successful peptide program.

• Rfc Endotoxin Testing: A Sustainable Alternative To LAL

  9/24/2026

  Recombinant Factor C testing offers a pharmacopeia-recognized, animal-free alternative to LAL with fewer interference risks, but regulatory hesitation slows adoption across the industry.